A phase 1 dose escalation study of a novel coupled CAR T cell therapy, GCC19CART, for patients with metastatic colorectal cancer. A new prognostic tool for metastatic colorectal cancer patients ...

AIA Life Insurance Korea has strengthened its cancer insurance offering after receiving nine months of exclusive usage rights for a new rider ...

Over 100 doctors gathered in Puducherry to discuss advancements in breast and gynaecological oncology at the IC-CON 2026 ...

Stage 1 mesothelioma is localized. The cancer is confined to one side of the chest lining or one area of the abdomen and has not spread to lymph nodes or distant organs. At this stage, treatment may ...

Section 7 of the National Institute for Health and Care Excellence (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013 requires integrated care ...

Researchers at Nagoya University have reported that ovarian cancer cells form hybrid clusters with mesothelial cells in abdominal fluid, a process that appears to accelerate tissue invasion and ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the ‘Population and treatments’ and ‘Unit costs’ worksheets in the template to reflect local ...

After spending decades helping others, Troy "T-bone" Wilson is asking for support as the long time Victoria mentor, volunteer ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous ...

A new UCLA investigator-initiated study has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise for some patients with borderline-resectable pancreatic ...

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...